Goodwill of Astrana Health, Inc. from 31 Jan 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Astrana Health, Inc. quarterly Goodwill in USD history and change rate from 31 Jan 2011 to 30 Sep 2025.
  • Astrana Health, Inc. Goodwill for the quarter ending 30 Sep 2025 was $863,266,000, a 111% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Astrana Health, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $863,266,000 +$453,555,000 +111% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $416,917,000 +$7,336,000 +1.8% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $416,386,000 +$6,119,000 +1.5% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $419,253,000 +$140,422,000 +50% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $409,711,000 +$134,183,000 +49% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $409,581,000 +$135,552,000 +49% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $410,267,000 +$140,861,000 +52% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $278,831,000 +$9,778,000 +3.6% 31 Dec 2023 10-K 14 Mar 2025 2024 FY
Q3 2023 $275,528,000 +$24,668,000 +9.8% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $274,029,000 +$27,341,000 +11% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $269,406,000 +$23,649,000 +9.6% 31 Mar 2023 10-Q/A 09 Aug 2023 2023 Q1
Q4 2022 $269,053,000 +$22,637,000 +9.2% 31 Dec 2022 10-K 14 Mar 2025 2024 FY
Q3 2022 $250,860,000 +$14,130,000 +6% 30 Sep 2022 10-K/A 09 Aug 2023 2022 FY
Q2 2022 $246,688,000 +$14,257,000 +6.1% 30 Jun 2022 10-K/A 09 Aug 2023 2022 FY
Q1 2022 $245,757,000 +$13,326,000 +5.7% 31 Mar 2022 10-K/A 09 Aug 2023 2022 FY
Q4 2021 $246,416,000 +$13,986,000 +6% 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $236,730,000 -$2,323,000 -0.97% 30 Sep 2021 10-K/A 09 Aug 2023 2022 FY
Q2 2021 $232,431,000 -$6,622,000 -2.8% 30 Jun 2021 10-K/A 09 Aug 2023 2022 FY
Q1 2021 $232,431,000 -$6,108,000 -2.6% 31 Mar 2021 10-K/A 09 Aug 2023 2022 FY
Q4 2020 $232,430,000 -$6,075,000 -2.5% 31 Dec 2020 10-K/A 09 Aug 2023 2022 FY
Q3 2020 $239,053,000 +$1,918,228 +0.81% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $239,053,000 +$29,739,176 +14% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $238,539,000 +$52,733,120 +28% 31 Mar 2020 10-Q 29 May 2020 2020 Q1
Q4 2019 $238,505,000 +$52,699,000 +28% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $237,134,772 +$47,530,026 +25% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $209,313,824 +$19,709,078 +10% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $185,805,880 -$3,127,311 -1.7% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $185,806,000 -$4,041,202 -2.1% 31 Dec 2018 10-K 15 Mar 2021 2020 FY
Q3 2018 $189,604,746 +$187,982,263 +11586% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $189,604,746 +$187,982,263 +11586% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $188,933,191 +$187,310,708 +11545% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $189,847,202 +$86,439,851 +84% 31 Dec 2017 10-K 16 Mar 2020 2019 FY
Q3 2017 $1,622,483 $0 0% 30 Sep 2017 10-Q 14 Nov 2017 2018 Q2
Q2 2017 $1,622,483 $0 0% 30 Jun 2017 10-Q 14 Aug 2017 2018 Q1
Q1 2017 $1,622,483 $0 0% 31 Mar 2017 10-Q 14 Nov 2017 2018 Q2
Q4 2016 $103,407,351 +$2,556,207 +2.5% 31 Dec 2016 10-K 18 Mar 2019 2018 FY
Q3 2016 $1,622,483 -$546,350 -25% 30 Sep 2016 10-Q 14 Nov 2016 2017 Q2
Q2 2016 $1,622,483 -$546,350 -25% 30 Jun 2016 10-Q 15 Aug 2016 2017 Q1
Q1 2016 $1,622,483 -$546,350 -25% 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q4 2015 $100,851,144 +$99,464,664 +7174% 31 Dec 2015 10-K 02 Apr 2018 2017 FY
Q3 2015 $2,168,833 +$1,729,139 +393% 30 Sep 2015 10-Q 17 Nov 2015 2016 Q2
Q2 2015 $2,168,833 +$1,890,698 30 Jun 2015 10-Q 28 Aug 2015 2016 Q1
Q1 2015 $2,168,833 +$1,674,133 +338% 31 Mar 2015 10-K 29 Jun 2017 2017 FY
Q4 2014 $1,386,480 +$891,780 +180% 31 Dec 2014 10-Q 23 Feb 2015 2015 Q3
Q3 2014 $439,694 +$181,494 30 Sep 2014 10-Q 14 Nov 2014 2015 Q2
Q2 2014 $278,135* +$244,935 30 Jun 2014 10-Q 14 Aug 2014 2015 Q1
Q1 2014 $494,700 +$461,500 31 Mar 2014 10-K 29 Jun 2016 2016 FY
Q4 2013 $494,700 +$461,500 31 Jan 2014 10-K 14 Jul 2015 2015 FY
Q3 2013 $258,200* +$226,200 31 Oct 2013 10-Q 20 Dec 2013 2013 Q3
Q2 2013 $33,200* +$1,200 31 Jul 2013 10-Q 16 Sep 2013 2013 Q2
Q1 2013 $33,200* -$16,800 30 Apr 2013 10-Q 14 Jun 2013 2013 Q1
Q4 2012 $33,200* +$1,200 31 Jan 2013 10-K 08 May 2014 2013 FY
Q3 2012 $32,000* -$18,000 31 Oct 2012 10-Q 17 Dec 2012 2012 Q3
Q2 2012 $32,000* 31 Jul 2012 10-Q 14 Sep 2012 2012 Q2
Q1 2012 $50,000* 30 Apr 2012 10-Q 19 Jun 2012 2012 Q1
Q4 2011 $32,000* +$32,000 31 Jan 2012 10-K 08 May 2014 2013 FY
Q3 2011 $50,000* 31 Oct 2011 10-Q/A 10 Apr 2012 2011 Q3
Q4 2010 $0 31 Jan 2011 10-K 01 May 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.